Ledger.Open graph →
SEC Form D · filed April 11, 2025

Atsena Therapeutics, Inc

Offering
$150.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jennifer Wellman · Durham, NCDirectorPatrick Ritschel · Durham, NCExec · DirectorChristina Isacson · Durham, NCDirectorJacqueline Grant · Durham, NCDirectorJoe Zakrzewski · Durham, NCDirectorPatrick Ritschel · Durham, NCExec · DirectorJacqueline Grant · Durham, NCDirectorJennifer Wellman · Durham, NCDirectorChristina Isacson · Durham, NCDirectorChris Carpenter · Durham, NCDirectorNorbert Riedel · Chicago, ILDirectorMatthew Romney · Salt Lake City, UTDirectorCraig Murli · EMERYVILLE, CADirectorGabriel K. Segal · VANCOUVER, British Columbia, CanadaExec · DirectorJudson K. Lacapra · VANCOUVER, British Columbia, CanadaDirectorChris Carpenter · Durham, NCDirectorNorbert Riedel · Chicago, ILDirectorJoe Zakrzewski · Durham, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗